BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 21122202)

  • 1. [The use of recombinant human B-type natriuretic peptide for the protection of cardiac and renal functions in heart failure patients with acute anterior myocardial infarction in peri-operative period of primary percutaneous coronary intervention].
    Zhang J; Fu XH; Fan XN; Jia XW; Gu XS; Li SQ; Jiang YF; Fan WZ; Su JL
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Nov; 22(11):669-73. PubMed ID: 21122202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute hemodynamic effects of intravenous recombinant human brain natriuretic peptide in patients with acute myocardial infarction complicated with heart failure].
    Li SQ; Fu XH; Liu J; Gu XS; Zhang J; Fan XN; Jiang YF; Miao Q
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jan; 34(1):23-7. PubMed ID: 16626544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-type natriuretic peptide for prevention of contrast-induced nephropathy in patients with heart failure undergoing primary percutaneous coronary intervention.
    Zhang J; Fu X; Jia X; Fan X; Gu X; Li S; Wu W; Fan W; Su J; Hao G; Jiang Y; Xue L
    Acta Radiol; 2010 Jul; 51(6):641-8. PubMed ID: 20438292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic effect of recombinant human brain natriuretic peptide for treatment of decompensated heart failure: comparison with nitroglycerin].
    Xie CL; Meng SR; Wang W; Chen SM; Li P; Feng XG
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):839-42. PubMed ID: 18504215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of the effects of intravenous recombinant human brain natriuretic peptide and nitroglycerin in patients with decompensated acute heart failure: a multicenter, randomized, open-label, parallel-design study].
    Recombinant Human Brain Natriuretic Peptide Study Group
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Mar; 34(3):222-6. PubMed ID: 16630454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of primary percutaneous coronary intervention on plasma B-type natriuretic peptide in patients with acute myocardial infarction].
    Liang JQ; Zhou XX; Huang YG; Zhang GX
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Dec; 25(12):1555-7. PubMed ID: 16361163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NT pro-B-type natriuretic peptide levels are related to microvascular reperfusion in patients undergoing direct percutaneous transluminal coronary angioplasty for anterior ST-segment elevation myocardial infarction.
    Rossetti E; Mariani M; Poli A; Palmerini T; Finazzi S; Lotzniker M; Sangiorgi D; De Servi S
    J Cardiovasc Med (Hagerstown); 2010 May; 11(5):359-64. PubMed ID: 20051875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of left ventricular ejection fraction on clinical long-term follow-up outcomes in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
    Wang CH; Xie XJ; Fang Q; Zhang SY; Fang ZJ; Jiang XF; Xie HZ; Liu ZY; Shen ZJ
    Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(4):265-8. PubMed ID: 21418873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recombinant human brain natriuretic peptide on the cardiac hemodynamics and renal function in dogs with heart failure].
    Xu XW; Zeng GY; Yang Y; Liu HX
    Yao Xue Xue Bao; 2002 Oct; 37(10):758-62. PubMed ID: 12567856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human brain natriuretic peptide therapy combined with bone mesenchymal stem cell transplantation for treating heart failure in rats.
    Zhang J; Zhang L; Wu Q; Liu H; Huang L
    Mol Med Rep; 2013 Feb; 7(2):628-32. PubMed ID: 23165804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Brain natriuretic peptide and left ventricular remodeling after emergency percutaneous coronary intervention in acute myocardial infarction patients].
    Yu XY; Liu CZ; Wang JH; Sun JJ; Zhang HT; Luo HL; Huang CC; Jiang YQ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Apr; 20(4):204-6. PubMed ID: 18419951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of pretreatment with recombinant human B-type natriuretic peptide on infarct size in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
    Li S; Fu X; Dai Y; Liu C; Wang Y; Li W; Wu W; Gu X; Hao G; Fan W; Miao Q; Jiang Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Nov; 43(11):954-9. PubMed ID: 26888806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of recombinant human brain natriuretic peptide on the prognosis of patients with acute anterior myocardial infarction undergoing primary percutaneous coronary intervention: a prospective, multi-center, randomized clinical trial.
    Miao ZL; Hou AJ; Zang HY; Huang RG; Zheng XQ; Lin HL; Wang W; Hou P; Xia F; Li ZQ
    J Thorac Dis; 2017 Jan; 9(1):54-63. PubMed ID: 28203406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple biomarkers at admission are associated with angiographic, electrocardiographic, and imaging cardiovascular mechanistic markers of outcomes in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.
    Damman P; Kuijt WJ; Woudstra P; Haeck JD; Koch KT; Gu YL; van Straalen JP; Fischer J; Tijssen JG; Krucoff MW; de Winter RJ
    Am Heart J; 2012 May; 163(5):783-9. PubMed ID: 22607855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic value of plasma brain natriuretic peptide and C-reactive protein in patients with acute coronary syndromes underwent percutaneous coronary intervention].
    He B; Ding S; Pu J; Liu JP; Song W; Du YP; Shen JY; Jin SX; Sun Y; Shen L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):349-52. PubMed ID: 16776932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of intracoronary administration of anisodamine on no-reflow, ventricular function and systolic synchrony in acute myocardial infarction patients undergoing percutaneous coronary intervention].
    Fan WZ; Fu XH; Jiang YF; Gu XS; Wu WL; Li SQ; Liu J; Xue L; Wei YY; Hao GZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Oct; 35(10):908-13. PubMed ID: 18206037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of rhBNP on renal function in STEMI-HF patients with mild renal insufficiency undergoing primary PCI.
    Xing K; Fu X; Wang Y; Li W; Gu X; Hao G; Miao Q; Li S; Jiang Y; Fan W; Geng W
    Heart Vessels; 2016 Apr; 31(4):490-8. PubMed ID: 25637044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-hospital prognostic value of admission plasma B-type natriuretic peptide levels in patients undergoing primary angioplasty for acute ST-elevation myocardial infarction.
    Oduncu V; Erkol A; Tanalp AC; Dündar C; Tanboğa IH; Sırma D; Karagöz A; Karabay CY; Izgi A; Pala S; Tigen K; Kırma C
    Turk Kardiyol Dern Ars; 2011 Oct; 39(7):540-8. PubMed ID: 21983763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of ST resolution analysis performed immediately versus at ninety minutes after primary percutaneous coronary intervention.
    Kumar S; Sivagangabalan G; Hsieh C; Ryding AD; Narayan A; Chan H; Burgess DC; Ong AT; Sadick N; Kovoor P
    Am J Cardiol; 2010 Feb; 105(4):467-74. PubMed ID: 20152240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.